Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Testosterone is crucial for development, growth, and various body functions in mammals.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

The healthcare for transgender veterans could be better with a more unified team approach.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

The document concludes that more research is needed to fully understand the causes of PCOS.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Women may need different blood pressure guidelines than men for heart disease prevention.

The testes produce sperm and hormones essential for male development.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.